CAPR:US
$10.21
3.236%
Capricor Therapeutics Inc.News & Events
Last updated: Jun 2, 2025, 7:56 PM ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
GlobeNewswire JUN 2, 2025 1:55 PM EDTNEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of in...READ ARTICLEINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
PR Newswire JUN 1, 2025 10:00 AM EDTINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therape...READ ARTICLEINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
GlobeNewswire MAY 28, 2025 9:00 AM EDTNEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inv...READ ARTICLEINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
PR Newswire MAY 26, 2025 10:00 AM EDTINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therape...READ ARTICLEINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
GlobeNewswire MAY 22, 2025 9:00 AM EDTNEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inv...READ ARTICLEINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
PR Newswire MAY 20, 2025 9:00 AM EDTINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therape...READ ARTICLECAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
PR Newswire MAY 20, 2025 5:26 AM EDTCAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the ...READ ARTICLEINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
GlobeNewswire MAY 18, 2025 10:00 AM EDTNEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inv...READ ARTICLECAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Business Wire MAY 16, 2025 6:36 PM EDTThe Schall Law Firm , a national shareholder rights litigation firm, announces that it is inves...READ ARTICLECapricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire MAY 13, 2025 4:05 PM EDTBiologics License Application (BLA) for deramiocel in the treatment of Duchenne muscular dystroph...READ ARTICLE